TIMOTHY E GUERTIN
CIK 1217440 · President and CEO · last filed 2026-02-13
TIMOTHY E GUERTIN is a President and CEO who has filed 111 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for VREX, was dated Feb 13, 2026. Across all open-market trades the lifetime net is −$146.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $24.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$24.13M
4
111
-$146.20M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VREX | Director | 26,777 | $12.41 | $332.3K | $0 | 9 | 2026-02-13 |
| TER | Director | 62,729 | $379.31 | $23.79M | -$830.7K | 27 | 2024-03-19 |
| VARIAN MEDICAL SYSTEMS INC (VAR) Delisted | Director | 42,053 | $177.07 | $7.45M | -$116.20M | 58 | 2020-02-12 |
| VARIAN MEDICAL SYSTEMS INC (VARI) Delisted | President and CEO | 177,389 | — | — | -$29.17M | 16 | 2010-05-17 |
Recent Filings
111 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-13 | VREX | Grant (A) | — | $0 | EDGAR |
| 2026-02-09 | VREX | Exer (M) | +8,483 | $0 | EDGAR |
| 2025-02-14 | VREX | Mixed | +6,573 | $0 | EDGAR |
| 2024-05-16 | TER | Notice (144) | −59,882 | -$7.92M | EDGAR |
| 2024-03-19 | TER | Other (J) | +69 | $0 | EDGAR |
| 2024-02-12 | VREX | Mixed | +6,881 | $0 | EDGAR |
| 2023-12-21 | TER | Other (J) | +63 | $0 | EDGAR |
| 2023-09-27 | TER | Other (J) | +67 | $0 | EDGAR |
| 2023-06-20 | TER | Other (J) | +58 | $0 | EDGAR |
| 2023-05-16 | TER | Grant (A) | +2,530 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.